Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment

por Okumura, Lucas M., Antunes, Valquíria D., Aguiar, Karina S., Farias, Tatiane, Andrzejevski, Vânia M., Funke, Vaneuza M.
Publicado 2015